Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Clinical trial NCT00406458 · COMPLETED

Trial details

NCT number: NCT00406458
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetic Polyneuropathy

Start date: 2006-11-01
Primary completion: 2008-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.